Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression. - Ding, Ziqiang; Sun, Shuyang; Wang, Xuan; Yang, Xiaomei; Shi, Wei; Huang, Xianing; Xie, Shenxia; Mo, Fengzhen; Hou, Xiaoqiong; Liu, Aiqun; Jiang, Xiaobing; Tang, Zhuoran; et al. (Journal of Hematology & Oncology, 2023)